São Paulo - Delayed Quote BRL

Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA)

Compare
2.2500
+0.0600
+(2.74%)
At close: 5:54:55 PM GMT-3
Currency in BRL All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,095,433.0000
5,488,776.0000
4,088,252.0000
2,702,066.0000
2,035,191.0000
Cost of Revenue
4,051,328.0000
3,560,200.0000
2,636,145.0000
1,833,275.0000
1,399,514.0000
Gross Profit
2,044,105.0000
1,928,576.0000
1,452,107.0000
868,791.0000
635,677.0000
Operating Expense
1,309,759.0000
1,188,696.0000
1,006,230.0000
694,895.0000
616,061.0000
Operating Income
734,346.0000
739,880.0000
445,877.0000
173,896.0000
19,616.0000
Net Non Operating Interest Income Expense
-596,563.0000
-537,293.0000
-438,700.0000
-114,831.0000
-72,871.0000
Pretax Income
178,942.0000
302,518.0000
121,540.0000
62,337.0000
-53,255.0000
Tax Provision
50,135.0000
-10,044.0000
7,770.0000
84,754.0000
68,087.0000
Net Income Common Stockholders
72,393.0000
223,618.0000
46,260.0000
-46,900.0000
-157,687.0000
Diluted NI Available to Com Stockholders
72,393.0000
223,618.0000
46,260.0000
-46,900.0000
-157,687.0000
Basic EPS
0.14
0.43
0.10
-0.11
-0.39
Diluted EPS
0.13
0.42
0.09
-0.11
-0.39
Basic Average Shares
583,870.6320
523,653.3490
479,831.3990
412,479.6030
401,816.3850
Diluted Average Shares
592,155.0510
535,516.7450
531,699.2870
412,479.6030
401,816.3850
Total Operating Income as Reported
--
758,018.0000
470,565.0000
177,215.0000
19,616.0000
Total Expenses
5,361,087.0000
4,748,896.0000
3,642,375.0000
2,528,170.0000
2,015,575.0000
Net Income from Continuing & Discontinued Operation
72,393.0000
223,618.0000
46,260.0000
-46,900.0000
-157,687.0000
Normalized Income
102,839.4557
207,176.7400
60,071.7192
-49,059.5200
-157,687.0000
Interest Income
12,972.0000
23,231.0000
7,710.0000
3,081.0000
21,932.0000
Interest Expense
597,467.0000
559,788.0000
396,473.0000
154,361.0000
94,803.0000
Net Interest Income
-596,563.0000
-537,293.0000
-438,700.0000
-114,831.0000
-72,871.0000
EBIT
776,409.0000
862,306.0000
518,013.0000
216,698.0000
41,548.0000
EBITDA
1,051,747.0000
1,119,671.0000
693,165.0000
343,671.0000
148,361.0000
Reconciled Cost of Revenue
4,051,328.0000
3,560,200.0000
2,636,145.0000
1,833,275.0000
1,399,514.0000
Reconciled Depreciation
275,338.0000
257,365.0000
175,152.0000
126,973.0000
106,813.0000
Net Income from Continuing Operation Net Minority Interest
72,393.0000
223,618.0000
46,260.0000
-46,900.0000
-157,687.0000
Total Unusual Items Excluding Goodwill
-42,297.0000
24,911.0000
-14,755.0000
3,272.0000
888.0000
Total Unusual Items
-42,297.0000
24,911.0000
-14,755.0000
3,272.0000
888.0000
Normalized EBITDA
1,094,044.0000
1,094,760.0000
707,920.0000
340,399.0000
148,361.0000
Tax Rate for Calcs
0.0003
0.0003
0.0001
0.0003
0.0003
Tax Effect of Unusual Items
-11,850.5443
8,469.7400
-943.2808
1,112.4800
--
12/31/2020 - 9/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade